PharmaCielo Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
268
- Stock Symbol
-
PCLO
- Investments
-
5
- Share Price
-
$0.07
- (As of Friday Closing)
PharmaCielo General Information
Description
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of its revenue in the form of the Sale of Cannabis derivative products in Colombia.
Contact Information
Website
www.pharmacielo.comCorporate Office
- 82 Richmond Street East
- Suite 200
- Toronto, Ontario M5C 1P1
- Canada
Corporate Office
- 82 Richmond Street East
- Suite 200
- Toronto, Ontario M5C 1P1
- Canada
PharmaCielo Stock Performance
As of 17-Jan-2025, PharmaCielo’s stock price is $0.07. Its current market cap is $12.4M with 170M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.07 | $0.08 | $0.05 - $0.21 | $12.4M | 170M | 188K | -$0.07 |
PharmaCielo Financials Summary
As of 30-Sep-2024, PharmaCielo has a trailing 12-month revenue of $1.91M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 37,292 | 34,778 | 27,654 | 112,472 |
| Revenue | 1,908 | 1,142 | 4,074 | 1,551 |
| EBITDA | (6,838) | (9,026) | (8,752) | (19,806) |
| Net Income | (10,311) | (12,068) | (11,141) | (21,231) |
| Total Assets | 14,588 | 16,802 | 18,506 | 28,201 |
| Total Debt | 15,469 | 13,801 | 9,274 | 6,612 |
PharmaCielo Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PharmaCielo Comparisons
Industry
Financing
Details
PharmaCielo Competitors (1)
One of PharmaCielo’s competitors is Khiron Life Sciences, a Corporation company based in Toronto, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Khiron Life Sciences | Corporation | Toronto, Canada |
PharmaCielo Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PharmaCielo Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
PharmaCielo Investments & Acquisitions (5)
PharmaCielo’s most recent deal was a Merger/Acquisition with Ubiquo Telemedicina for . The deal was made on 26-Jul-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ubiquo Telemedicina | 26-Jul-2019 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| PharmaCielo México | 25-Jan-2019 | Joint Venture | Pharmaceuticals | ||
| AAJ Capital 1 | 15-Jan-2019 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) | ||
| 3.37 hectares land (Bogota) | 17-May-2017 | Corporate Asset Purchase | Buildings and Property | ||
| Siam Ventures | Merger/Acquisition | BPO/Outsource Services |
PharmaCielo ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
PharmaCielo FAQs
-
When was PharmaCielo founded?
PharmaCielo was founded in 2014.
-
Where is PharmaCielo headquartered?
PharmaCielo is headquartered in Toronto, Canada.
-
What is the size of PharmaCielo?
PharmaCielo has 268 total employees.
-
What industry is PharmaCielo in?
PharmaCielo’s primary industry is Other Consumer Non-Durables.
-
Is PharmaCielo a private or public company?
PharmaCielo is a Public company.
-
What is PharmaCielo’s stock symbol?
The ticker symbol for PharmaCielo is PCLO.
-
What is the current stock price of PharmaCielo?
As of 17-Jan-2025 the stock price of PharmaCielo is $0.07.
-
What is the current market cap of PharmaCielo?
The current market capitalization of PharmaCielo is $12.4M.
-
What is PharmaCielo’s current revenue?
The trailing twelve month revenue for PharmaCielo is $1.91M.
-
Who are PharmaCielo’s competitors?
Khiron Life Sciences is a competitor of PharmaCielo.
-
What is PharmaCielo’s annual earnings per share (EPS)?
PharmaCielo’s EPS for 12 months was -$0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
